Kirk Look - 12 Feb 2026 Form 4 Insider Report for ONCOLYTICS BIOTECH INC (ONCY)

Role
Chief Financial Officer
Signature
/s/ Kirk Look
Issuer symbol
ONCY
Transactions as of
12 Feb 2026
Net transactions value
+$10,104
Form type
4
Filing time
13 Feb 2026, 07:00:30 UTC
Previous filing
02 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Look Kirk Chief Financial Officer C/O ONCOLYTICS BIOTECH INC., 4350 EXECUTIVE DRIVE, SUITE 325, SAN DIEGO /s/ Kirk Look 13 Feb 2026 0002103582

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONCY Common Shares Purchase $10,104 +12,000 +4.4% $0.8420 287,515 12 Feb 2026 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.